化合物Tyrphostin AG957u00A0 T21785
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 140674-76-6 | ¥1,820.00 | 询底价 |
1 mg | 140674-76-6 | ¥813.00 | 询底价 |
25 mg | 140674-76-6 | ¥4,870.00 | 询底价 |
5 mg | 140674-76-6 | ¥1,980.00 | 询底价 |
10 mg | 140674-76-6 | ¥2,950.00 | 询底价 |
2 mg | 140674-76-6 | ¥1,180.00 | 询底价 |
50 mg | 140674-76-6 | ¥6,760.00 | 询底价 |
100 mg | 140674-76-6 | ¥8,930.00 | 询底价 |
Product Introduction
Bioactivity
英文名: AG957
描述: Tyrphostin AG957 是一种酪氨酸激酶抑制剂,具有抗BCR/ABL 酪氨酸激酶活性。它能够抑制p210bcr/abl 酶活性 (IC50:2.9 μM)。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 60 mg/ml (219.56 mM)
关键字: paxillin | NSC654705 | c-Abl | Bcr-Abl | lipopolysaccharide | AG 957 | Tyrphostin AG-957 | integrins | leukemia | tyrosine | Tyrphostin AG 957 | hematopoiesis | NSC-654705 | NSC 654705 | AG-957 | Tyrphostin AG957 | AG957 | kinase | BCR/ABL | inhibit | cytoskeleton | Inhibitor | Chronic | myelogenous
相关产品: Berbamine dihydrochloride | CZC-8004 | Masitinib | Rigosertib | GNF-5 | Vamotinib | NVP-BAW2881 | NVP-BHG712 | GMB-475 | Pivanex
相关库: Anti-Cancer Metabolism Compound Library | Anti-Cancer Compound Library | Angiogenesis related Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Kinase Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Tyrosine Kinase Inhibitor Library | Hematonosis Compound Library | Bioactive Compound Library
化合物Tyrphostin AG957u00A0 T21785信息由TargetMol中国为您提供,如您想了解更多关于化合物Tyrphostin AG957u00A0 T21785报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途